publication venue for
- Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study.. 22:81. 2024
- Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients. 17:24. 2019
- Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill. 17:6. 2019
- International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER). 17:7. 2019
- Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis. 16:29. 2018
- Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study. 16:31. 2018
- Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study. 16:34. 2018
- Management of venous thromboembolism: an update. 14:23. 2016
- XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis. 12:16. 2014
- Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study. 6:15-15. 2008
- Traumatic deep vein thrombosis in a soccer player: A case study.. 2:8-8. 2004